Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non –Small Cell Lung Cancer

Genetic testing for nonsquamous advanced non –small cell lung cancer (aNSCLC) is recommended to guide first-line therapy. Activating mutations can be identified via single-gene testing or next-generation sequencing (NGS).

Source: Value in Health - June 8, 2018 Category: International Medicine & Public Health Authors: Tiffany M. Yu, Carl Morrison, Edward J. Gold, Alison Tradonsky, Ren ée J.G. Arnold Source Type: research